TSHA Long Call Strategy
TSHA (Taysha Gene Therapies, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.
TSHA (Taysha Gene Therapies, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.67B, a beta of 1.23 versus the broader market, a 52-week range of 2.25-7.3, average daily share volume of 2.8M, a public-listing history dating back to 2020, approximately 73 full-time employees. These structural characteristics shape how TSHA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.23 places TSHA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on TSHA?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current TSHA snapshot
As of May 15, 2026, spot at $5.95, ATM IV 102.70%, IV rank 14.02%, expected move 29.44%. The long call on TSHA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on TSHA specifically: TSHA IV at 102.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a TSHA long call, with a market-implied 1-standard-deviation move of approximately 29.44% (roughly $1.75 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TSHA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TSHA should anchor to the underlying notional of $5.95 per share and to the trader's directional view on TSHA stock.
TSHA long call setup
The TSHA long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TSHA near $5.95, the first option leg uses a $5.95 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TSHA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TSHA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.95 | N/A |
TSHA long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
TSHA long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on TSHA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on TSHA
Long calls on TSHA express a bullish thesis with defined risk; traders use them ahead of TSHA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
TSHA thesis for this long call
The market-implied 1-standard-deviation range for TSHA extends from approximately $4.20 on the downside to $7.70 on the upside. A TSHA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current TSHA IV rank near 14.02% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TSHA at 102.70%. As a Healthcare name, TSHA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TSHA-specific events.
TSHA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TSHA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TSHA alongside the broader basket even when TSHA-specific fundamentals are unchanged. Long-premium structures like a long call on TSHA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current TSHA chain quotes before placing a trade.
Frequently asked questions
- What is a long call on TSHA?
- A long call on TSHA is the long call strategy applied to TSHA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With TSHA stock trading near $5.95, the strikes shown on this page are snapped to the nearest listed TSHA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TSHA long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the TSHA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 102.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TSHA long call?
- The breakeven for the TSHA long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TSHA market-implied 1-standard-deviation expected move is approximately 29.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on TSHA?
- Long calls on TSHA express a bullish thesis with defined risk; traders use them ahead of TSHA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current TSHA implied volatility affect this long call?
- TSHA ATM IV is at 102.70% with IV rank near 14.02%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.